This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McDonald, P. C. Articles by Dedhar, S. Search for Related Content PubMed PubMed Citation Articles by McDonald, P. C. Articles by Dedhar, S.

Rictor and Integrin-Linked Kinase Interact and Regulate Akt Phosphorylation and Cancer Cell Survival

Departments of ¹ Cancer Genetics and ² Advanced Therapeutics, BC Cancer Research Centre, British Columbia Cancer Agency; and ³ Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada

Requests for reprints: Shoukat Dedhar, BC Cancer Research Centre, British Columbia Cancer Agency, 675 West 10th Avenue, Vancouver BC, Canada V5Z 1L3. Phone: 604-675-8029; Fax: 604-675-8184; E-mail: sdedhar{at}interchange.ubc.ca.

Key Words: cancer cell • Integrin-Linked Kinase • signal transduction

An unbiased proteomic screen to identify integrin-linked kinase (ILK) interactors revealed rictor as an ILK-binding protein. This finding was interesting because rictor, originally identified as a regulator of cytoskeletal dynamics, is also a component of mammalian target of rapamycin complex 2 (mTORC2), a complex implicated in Akt phosphorylation. These functions overlap with known ILK functions. Coimmunoprecipitation analyses confirmed this interaction, and ILK and rictor colocalized in membrane ruffles and leading edges of cancer cells. Yeast two-hybrid assays showed a direct interaction between the NH₂- and COOH-terminal domains of rictor and the ILK kinase domain. Depletion of ILK and rictor in breast and prostate cancer cell lines resulted in inhibition of Akt Ser⁴⁷³ phosphorylation and induction of apoptosis, whereas, in several cell lines, depletion of mTOR increased Akt phosphorylation. Akt and Ser⁴⁷³P-Akt were detected in ILK immunoprecipitates and small interfering RNA–mediated depletion of rictor, but not mTOR, inhibited the amount of Ser⁴⁷³P-Akt in the ILK complex. Expression of the NH₂-terminal (1–398 amino acids) rictor domain also resulted in the inhibition of ILK-associated Akt Ser⁴⁷³ phosphorylation. These data show that rictor regulates the ability of ILK to promote Akt phosphorylation and cancer cell survival. [Cancer Res 2008;68(6):1618–24]

This article has been cited by other articles:

				E. Ho, T. Irvine, G. J.A. Vilk, G. Lajoie, K. S. Ravichandran, S. J.A. D'Souza, and L. Dagnino Integrin-linked Kinase Interactions with ELMO2 Modulate Cell Polarity Mol. Biol. Cell, July 1, 2009; 20(13): 3033 - 3043. [Abstract] [Full Text] [PDF]

				S. Park, D. Zhao, K. J. Hatanpaa, B. E. Mickey, D. Saha, D. A. Boothman, M. D. Story, E. T. Wong, S. Burma, M.-M. Georgescu, et al. RIP1 Activates PI3K-Akt via a Dual Mechanism Involving NF-{kappa}B-Mediated Inhibition of the mTOR-S6K-IRS1 Negative Feedback Loop and Down-regulation of PTEN Cancer Res., May 15, 2009; 69(10): 4107 - 4111. [Abstract] [Full Text] [PDF]

				F. Meric-Bernstam and A. M. Gonzalez-Angulo Targeting the mTOR Signaling Network for Cancer Therapy J. Clin. Oncol., May 1, 2009; 27(13): 2278 - 2287. [Abstract] [Full Text] [PDF]

				J. A. Pereira, Y. Benninger, R. Baumann, A. F. Goncalves, M. Ozcelik, T. Thurnherr, N. Tricaud, D. Meijer, R. Fassler, U. Suter, et al. Integrin-linked kinase is required for radial sorting of axons and Schwann cell remyelination in the peripheral nervous system J. Cell Biol., April 6, 2009; 185(1): 147 - 161. [Abstract] [Full Text] [PDF]

				M. Breuleux, M. Klopfenstein, C. Stephan, C. A. Doughty, L. Barys, S.-M. Maira, D. Kwiatkowski, and H. A. Lane Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition Mol. Cancer Ther., April 1, 2009; 8(4): 742 - 753. [Abstract] [Full Text] [PDF]

				K. R. Legate, S. A. Wickstrom, and R. Fassler Genetic and cell biological analysis of integrin outside-in signaling Genes & Dev., February 15, 2009; 23(4): 397 - 418. [Abstract] [Full Text] [PDF]

				B. Vollenbroker, B. George, M. Wolfgart, M. A. Saleem, H. Pavenstadt, and T. Weide mTOR regulates expression of slit diaphragm proteins and cytoskeleton structure in podocytes Am J Physiol Renal Physiol, February 1, 2009; 296(2): F418 - F426. [Abstract] [Full Text] [PDF]

				S. Bergmann, A. Lang, M. Rohde, V. Agarwal, C. Rennemeier, C. Grashoff, K. T. Preissner, and S. Hammerschmidt Integrin-linked kinase is required for vitronectin-mediated internalization of Streptococcus pneumoniae by host cells J. Cell Sci., January 15, 2009; 122(2): 256 - 267. [Abstract] [Full Text] [PDF]

				D. R. Welch, C. R. Cooper, D. R. Hurst, C. C. Lynch, M. D. Martin, K. S. Vaidya, M. N. VanSaun, and A. M. Mastro Metastasis Research Society-American Association for Cancer Research Joint Conference on Metastasis Cancer Res., December 1, 2008; 68(23): 9578 - 9582. [Full Text] [PDF]

				P. C. McDonald, A. B. Fielding, and S. Dedhar Integrin-linked kinase - essential roles in physiology and cancer biology J. Cell Sci., October 1, 2008; 121(19): 3121 - 3132. [Abstract] [Full Text] [PDF]